Piloting a naloxone intervention in an emergency response community to reduce opioid overdoses in Philadelphia
Piloting a naloxone intervention in an emergency response community to reduce opioid overdoses in Philadelphia
批准号:
9403417
负责人:
Stephen E Lankenau
金额:
$22.79万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-07-01 至 2020-05-31
关键词:
AdherenceAreaBehaviorBehavioral ModelCellular PhoneCessation of lifeCommunitiesDataDevelopmentDiseaseDrug usageDrug userEffectivenessEmergency SituationEmergency medical serviceEmergency responseEpidemicEthicsEventFocus GroupsFundingGeographyGoalsHealthHealth PolicyHeroinHomicideIndividualInformation SystemsInjecting drug userInterventionInterviewKnowledgeLeadLifeLightLocationManualsMeasuresMissionModelingMorbidity - disease rateNaloxoneNarcotic AntagonistsOpioidOverdosePersonsPharmaceutical PreparationsPhiladelphiaPilot ProjectsPolicePopulationPrevention programProceduresPsyche structurePublic HealthReaction TimeRecruitment ActivityReportingResearchResearch PersonnelRisk BehaviorsSecureSiteSocial NetworkStatutes and LawsSupport GroupsTestingTimeTrainingUnited States National Institutes of HealthVehicle crashbasebehavioral responsecommunity interventiondesignexperiencefield studyhigh riskimplementation trialimprovedintervention programmembermisuse of prescription only drugsmortalitynoveloverdose deathoverdose preventionprescription opioid misuseprogramsprototyperesponsesocialsuccesstime useurban areausabilitywillingness
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
The escalating opioid overdose epidemic is one of the most serious public health problems confronting the
U.S. In 2014, a record 47,055 people died from a drug overdose in the U.S., which outnumbered deaths
from motor vehicle crashes by approximately one and a half times. Heroin and misuse of prescription
Death due to drug overdose is a significant and
rising cause of mortality and morbidity in Philadelphia. In 2015, almost 700 drug overdose deaths were
opioids
contributed to a majority of drug overdoses in 2014.
reported in Philadelphia – twice as many as deaths from homicide. In response, health policy, legislation,
and research funding are increasingly converging in support of the distribution of naloxone, an opioid
antagonist, and community-based opioid overdose prevention programs (OPP). The success of OPP is
contingent upon the willingness and effectiveness of bystanders to respond to an overdose event and
administer naloxone. Emergency Response Communities (ERC) are specialized smartphone-based social
networks in which members are approved carriers and/or potential users of a specific medication, such as
naloxone. The ERC approach is ideally suited to support, facilitate, and encourage naloxone administration
in opioid overdose emergencies, but is untested to date. The model combines GPS and IP-location tracking
to identify potential opioid overdose through a smartphone application or app. Towards this end, we are
proposing to utilize an ERC in the development and pilot testing of a
smartphone app-based naxolone
intervention (ERC-NAX) in Philadelphia.
Research is needed to understand the needs and barriers in
communities at high-risk for opioid overdose that will enable effective design, adaption, and implementation
of an ERC-NAX app.
pursue three specific
Guided by preliminary data from study investigators, the proposed pilot project will
aims: 1) Identify barriers and facilitators of acceptance and use of a smartphone-
based ERC naloxone intervention; 2) Pilot test the implementation of ERC-NAX in an ERC consisting of 55
non-medical opioid users and 55 community members; 3) Synthesize knowledge acquired in Aims 1 and 2
to be used in a subsequent R01 study to conduct a large-scale, multi-site implementation trial. This 3-year
study will provide actionable evidence regarding the viability and acceptance of an app-based naloxone
intervention following the ERC model. It will be developed and tested in partnership with two community
partners in Philadelphia with extensive experience in overdose prevention. This proposed intervention is
significant since it leverages the growing success of OPP and will empower communities
at high-risk for
to provide rapid, secure, and effective emergency response in the event of overdose. This
novel intervention, which is designed to augment emergency medical services in the rapid delivery of
opioid overdose
naloxone to overdose victims, may be effective at deescalating the epidemic of opioid overdose fatalities in
Philadelphia and communities elsewhere.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
UnityPhilly Response App for Overdose Reversal: Assessing Citywide Effectiveness and Sustainability
-
批准号:10585638
-
项目类别:
-
资助金额:$97.99万
-
财政年份:2023
-
负责人:Stephen E Lankenau
-
依托单位:
Medical Marijuana, Emerging Adults & Community: Connecting Health and Policy
-
批准号:8685230
-
项目类别:
-
资助金额:$69.86万
-
财政年份:2013
-
负责人:Stephen E Lankenau
-
依托单位:
Medical Marijuana, Emerging Adults & Community: Connecting Health and Policy
-
批准号:9228355
-
项目类别:
-
资助金额:$54.24万
-
财政年份:2013
-
负责人:Stephen E Lankenau
-
依托单位:
Medical Marijuana, Emerging Adults & Community: Connecting Health and Policy
-
批准号:8813547
-
项目类别:
-
资助金额:$76.86万
-
财政年份:2013
-
负责人:Stephen E Lankenau
-
依托单位:
Medical Marijuana, Emerging Adults, and Community: Connecting Health and Policy
-
批准号:10207574
-
项目类别:
-
资助金额:$81.99万
-
财政年份:2013
-
负责人:Stephen E Lankenau
-
依托单位:
Medical Marijuana, Emerging Adults, and Community: Connecting Health and Policy
-
批准号:10439715
-
项目类别:
-
资助金额:$81.23万
-
财政年份:2013
-
负责人:Stephen E Lankenau
-
依托单位:
Medical Marijuana, Emerging Adults & Community: Connecting Health and Policy
-
批准号:8503943
-
项目类别:
-
资助金额:$72.92万
-
财政年份:2013
-
负责人:Stephen E Lankenau
-
依托单位:
Medical Marijuana, Emerging Adults & Community: Connecting Health and Policy
-
批准号:8816603
-
项目类别:
-
资助金额:$10.05万
-
财政年份:2013
-
负责人:Stephen E Lankenau
-
依托单位:
Medical Marijuana, Emerging Adults, and Community: Connecting Health and Policy
-
批准号:9793996
-
项目类别:
-
资助金额:$82.52万
-
财政年份:2013
-
负责人:Stephen E Lankenau
-
依托单位:
Evaluation of Overdose Prevention Programs for Injection Drug Users
-
批准号:7686401
-
项目类别:
-
资助金额:$19.94万
-
财政年份:2009
-
负责人:Stephen E Lankenau
-
依托单位:
Non-Medical Prescription Drug Use Among High-Risk Youth
-
批准号:7319528
-
项目类别:
-
资助金额:$48.98万
-
财政年份:2007
-
负责人:Stephen E Lankenau
-
依托单位:
Non-Medical Prescription Drug Use Among High-Risk Youth
-
批准号:7501309
-
项目类别:
-
资助金额:$64.19万
-
财政年份:2007
-
负责人:Stephen E Lankenau
-
依托单位:
Non-Medical Prescription Drug Use Among High-Risk Youth
-
批准号:7937051
-
项目类别:
-
资助金额:$59.21万
-
财政年份:2007
-
负责人:Stephen E Lankenau
-
依托单位:
Non-Medical Prescription Drug Use Among High-Risk Youth
-
批准号:7680004
-
项目类别:
-
资助金额:$68.29万
-
财政年份:2007
-
负责人:Stephen E Lankenau
-
依托单位:
Ketamine Injection and HIV Risk Among High Risk Youth
-
批准号:7222911
-
项目类别:
-
资助金额:$2.77万
-
财政年份:2003
-
负责人:Stephen E Lankenau
-
依托单位:
Ketamine Injection and HIV Risk Among High Risk Youth
-
批准号:6747663
-
项目类别:
-
资助金额:$24.67万
-
财政年份:2003
-
负责人:Stephen E Lankenau
-
依托单位:
Ketamine Injection and HIV Risk Among High Risk Youth
-
批准号:6656710
-
项目类别:
-
资助金额:$50.74万
-
财政年份:2003
-
负责人:Stephen E Lankenau
-
依托单位:
Ketamine Injection and HIV Risk Among High Risk Youth
-
批准号:6930831
-
项目类别:
-
资助金额:$36.51万
-
财政年份:2003
-
负责人:Stephen E Lankenau
-
依托单位:
Ketamine Injection and HIV Risk Among High Risk Youth
-
批准号:6899660
-
项目类别:
-
资助金额:$67.31万
-
财政年份:2003
-
负责人:Stephen E Lankenau
-
依托单位:
Ketamine Injection and HIV Risk Among High Risk Youth
-
批准号:7060970
-
项目类别:
-
资助金额:$73.75万
-
财政年份:2003
-
负责人:Stephen E Lankenau
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: